Veterinary Medicine Information website

Depo-Medrone V 40 mg/ml Suspension for Injection

Authorised
  • Methylprednisolone acetate
Download as PDF

Product identification

Medicine name:
Depo-Medrone V 40 mg/ml Suspension for Injection
Active substance:
  • Methylprednisolone acetate
Target species:
  • Dog
  • Horse (non food-producing)
  • Cat
Route of administration:
  • Intraarticular use
  • Intramuscular use

Product details

Active substance and strength:
  • Methylprednisolone acetate
    40.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • 5 ml Type I glass vial with butyl rubber bung and aluminium overseal containing a white sterile aqueous suspension for injection.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pfizer Manufacturing Belgium
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10387/021/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/09/2025
Download